PolyPid Announces Eligibility for European Medicines Agency
Centralized Procedure Allows for Submission of a Single Marketing Application to the European Medicines Agency that, if Approved, Would Allow D-PLEX100 to...
Source: globenewswire.com
Page 10 - Polypid Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Polypid Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Polypid Ltd Today - Breaking & Trending Today
PolyPid Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results for D-PLEX₁₀₀ in the Prevention of Surgical Site Infections in Abdominal Surgery
Intends to discuss the Clinical Outcomes and Next Steps for D-PLEX100 for the Prevention of SSIs in Abdominal Surgery with the FDA and the EU Regulatory Authorities in Q1 2023 PETACH TIKVA,... | September 19, 2022
Source: marketscreener.com
PolyPid Announces Presentation of Phase 2 D-PLEX₁₀₀ Clinical Data at the European Society for Coloproctology Scientific Conference
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
PolyPid Announces Top-line Results of Phase 3 SHIELD I Trial of D-PLEX₁₀₀ for the Prevention of Surgical Site Infections in Abdominal Surgery
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
US Stocks Turn Lower After Jobs Report; Dow Dips 200 points
U.S. stocks turned lower toward the end of trading on Friday, following the release of jobs report for August. The Dow traded down 0.65% to 31,45...
Source: businessinsider.com